test samples

The procurement process for the contract titled "test samples," led by Cambridge University Hospitals NHS Foundation Trust, is focused on pathology services within the healthcare industry. The process, which has reached the contract award stage, began with a tender identified as "899" and concluded with a contract award to UK Biocentre Ltd. The contracting activity took place in the region of Cambridge, United Kingdom. The contract became active on 9th December 2025 and is set to last until 8th December 2026, with a gross value of £45,322.80.

Initiated as a below-threshold procurement, the process was completed under the legal framework outlined in UKPGA 2023/54. This tender presents valuable opportunities for businesses specialising in healthcare and pathology services, especially those capable of providing comprehensive test sample services. Companies engaged in delivering similar service-based offerings are well-suited to compete in this space, particularly if they can demonstrate efficiency and reliability.

As a large-scale supplier, UK Biocentre Ltd serves as an exemplar of the types of businesses that thrived in this procurement, emphasizing the growth potential for firms able to meet the NHS's stringent quality and service standards. Pursuing such contracts can establish long-term relationships with public health institutions and open doors to future collaborations.